REG-Acquisition of Own Shares
Lakefront Biotherapeutics NV repurchased 83,530 ordinary shares between June 22 and June 26, 2026, under the buyback program announced earlier in the month. The shares were acquired at an average price of €25.24 per share, for a total consideration of approximately €2.1 million.
Key figures
- Avg price eur
- 25.24
- Shares repurchased
- 83530
- Treasury shares held
- 199734
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.